🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I/II trial studies the side effects, best dose, and effect of ta...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2022-03-04
Trial ID
NCT05038592
Treatments Being Tested
This is a non-randomized, open-label, multicenter, dose escalation study de...
Status
Terminated
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2015-02
Trial ID
NCT02270463
Treatments Being Tested
This phase Ib/II trial tests the safety of tagraxofusp when given with or w...
Status
Withdrawn
Location
Habtemariam,Bruck
Start Date
2024-08-03
Trial ID
NCT05720988
Treatments Being Tested
This phase II trial studies how well venetoclax, SL-401, and chemotherapy w...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2020-05-29
Trial ID
NCT04216524
This is an open-label, multi-center, Phase 1/2 study to determine the MTD a...
Status
Active Not Recruiting
Location
Banner Health MD Anderson Cancer Center
Start Date
2018-01-02
Trial ID
NCT03386513
Treatments Being Tested
This phase Ib trial tests the safety, side effects, best dose and effective...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2025-01-28
Trial ID
NCT06498973
This phase II trial studies the side effects of tagraxofusp in treating pat...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2020-03-27
Trial ID
NCT04317781
Treatments Being Tested
A Phase 1/2, Open Label Study of SL-401 in Combination with Pomalidomide an...
Status
Terminated
Location
City of Hope
Start Date
2016-01
Trial ID
NCT02661022
Treatments Being Tested
This is an open-label Phase Ia/Ib clinical study of tagraxofusp-erzs, a nov...
Status
Terminated
Location
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2023-11-20
Trial ID
NCT05716009
Treatments Being Tested
This phase Ib/II trial studies the effects of tagraxofusp and low-intensity...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2022-02-17
Trial ID
NCT05032183